Occupational asthma is the most common form of occupational lung disease in the developed world at the present time. In this review, the epidemiology, pathogenesis/mechanisms, clinical presentations, management, and prevention of occupational asthma are discussed. The population attributable risk of asthma due to occupational exposures is considerable. Current understanding of the mechanisms by which many agents cause occupational asthma is limited, especially for lowmolecular-weight sensitizers and irritants. The diagnosis of occupational asthma is generally established on the basis of a suggestive history of a temporal association between exposure and the onset of symptoms and objective evidence that these symptoms are related to airflow limitation. Early diagnosis, elimination of exposure to the responsible agent, and early use of inhaled steroids may play important roles in the prevention of long-term persistence of asthma. Persistent occupational asthma is often associated with substantial disability and consequent impacts on income and quality of life. Prevention of new cases is the best approach to reducing the burden of asthma attributable to occupational exposures. Future research needs are identified.
Work-related asthma is the most common form of occupational lung disease, causing significant morbidity and disability. Workrelated asthma may be categorized into occupational asthma, which refers to new-onset asthma caused by exposure at the workplace, and work-aggravated asthma, in which preexisting asthma is exacerbated.
In this review, the epidemiology, pathogenesis/mechanisms, and clinical presentations of occupational asthma (both sensitizerand irritant-induced) are discussed. A diagnostic approach is presented, including history and exposure assessment, physical examination, and objective tests used to confirm both the diagnosis and work-relatedness of asthma. Management of the worker with occupational asthma is also addressed, including work modifications, prognosis, and impairment/disability assessment. Finally, the prevention of occupational asthma and future research needs are highlighted.
Definition/Classification of Occupational Asthma
Workplace exposure is an important cause of both new-onset asthma and exacerbations of preexisting disease. Although the term occupational asthma usually refers to new-onset asthma caused by exposure at the workplace, exacerbations of preexisting asthma are a potentially more important cause of morbidity because there are more workers with work-aggravated asthma than work-caused asthma.
How the various types of work-related asthma are defined often depends on the setting (e.g., epidemiologic research, disease surveillance, or workers' compensation). An accepted operational definition of occupational asthma for clinical purposes is variable airflow limitation and/or airway hyperresponsiveness due to exposure to a specific agent or conditions in a particular work environment and not to stimuli encountered outside the workplace (1) . This definition includes no reference to the mechanism of asthma induction, and therefore work-related variable airway obstruction caused by antigen-induced hypersensitivity reactions, pharmacologic effects, nonspecific inflammatory processes, and direct airway irritation can qualify as occupational asthma. In the past, the term occupational asthma often was used to refer only to patients with reversible airflow limitation due to sensitization to a substance encountered at work (i.e., immunologic or sensitizer-induced asthma) that involves a latent period. With such an approach, workers who develop persistent symptoms of asthma and nonspecific airway hyperresponsiveness promptly after short-term, high-intensity inhalational exposure to irritant materials would not be considered to have occupational asthma. The term reactive airways dysfunction syndrome (RADS) has been coined to refer to this condition (24. Recently, a consensus appears to be developing around the concept that there is a nonimmunologic type of occupational asthma (without latency) that may occur after single or multiple exposures to nonspecific irritant chemicals at concentrations high enough to induce airway injury and inflammation (1, 3) . Because RADS refers only to asthma occurring after a single high-intensity exposure, the term irritant-induced asthma is used in this paper. Recurrent exposure to an irritant before the onset of asthmatic symptoms may lead to blurring of the distinction based on latency.
Another type of disorder characterized by work-related variable airways limitation is associated with occupational exposure to organic dusts such as cotton, flax, hemp, jute, sisal, and various grains. Many but not all occupational lung disease experts consider organic dust-induced airways disease to be an asthmalike disorder rather than true asthma (1) (7) .
The prevalence of occupational asthma in various occupational cohort studies depends on the agent(s) to which the workers are exposed, levels of exposure, and host suseptibility factors such as atopy and cigarette smoking. The highest prevalences of occupational asthma have been reported with exposures to platinum salts and proteolytic enzymes used in the detergent industry (up to 50%) (8, 9) . In general, however, the prevalence of occupational asthma in most cohorts of workers exposed to a known sensitizing agent is less than 10% (10) . There are convincing data to indicate that the level of exposure is an important risk factor for sensitizer-induced occupational asthma (10) .
Atopy appears to be an important risk factor for occupational asthma due to IgEdependent mechanisms. Psyllium workers (11) , bakers (12) , and laboratory animal handlers (13) who are atopic have been shown to be at increased risk of developing occupational asthma compared to their non-atopic co-workers. Cigarette smoking also appears to increase risk of IgE-mediated occupational asthma. Workers who smoke and have been exposed to platinum salts, acid anhydrides, snow crab, green coffee beans, and ispaghula have been shown to have greater risk of developing occupational asthma than their nonsmoking coworkers (14) . In contrast, for most sensitizing agents that cause asthma through mechanisms not involving specific IgE antibodies, such as diisocyanates and western red cedar, atopy and smoking do not appear to be risk factors (15, 16) .
Little is known about the epidemiology of irritant-induced asthma, but it is likely a relatively rare outcome of irritant exposure.
SWORD data suggest that < 10% of reported inhalational injuries are followed by persistent asthma (17) . Irritant (18) . Level of exposure is likely to be a risk factor for irritant-induced asthma. In a study of hospital laboratory workers exposed to a spill of glacial acetic acid, the risk of irritant-induced asthma increased with level of exposure as assessed by distance from the spill (19) . Several studies have also suggested that atopy and smoking are risk factors for irritantinduced asthma (20, 21) .
Pathogenesis/Mechanisms
Immunologic or Sensitizer-Induced Occupational Asdtma
More than 250 agents have been adequately documented as causing immunologic occupational asthma (27) . (25) or diisocyanates (26) in sensitized subjects support this hypothesis. In nonoccupational allergic asthma, the majority of T-cell clones derived from the bronchial mucosa are CD4+, whereas in diisocyanate-induced asthma, the majority are CD8+ (27) . Interestingly, an increased percentage of CD8+ T cells and increased production of interleukin (IL)-5 have been found in bronchoalveolar lavage fluid from nonatopic asthmatics (28) .
Recent investigations into the genetic determinants of risk for sensitizer-induced occupational asthma suggest that polymorphisms in genes encoding major histocompatibility complex (MHC) class II proteins may be important determinants of the specificity of response to sensitizing agents. In workers with exposure to diisocyanates, HLA-DQB1*0503 and DQB1*0201/0301 alleles are associated with asthma, whereas HLA-DQB1*O501 and DQA1*0101-DQB1*0501-DR1 appear to be protective (29) . The alleles, HLA-DQB1*0503 and HLA-DQB1*0501, differ at residue 57 for a single amino acid, aspartic acid in DQB1*0503 and valine in DQB1*0501, suggesting that residue 57 may be a potentially critical location in the development of asthma (30) . Associations with MHC proteins have also been described in acid anhydride-induced asthma (31), in platinum salts-induced asthma, and in red cedar-induced asthma (32) . The DRB 1 * 13 marker was associated with the risk of soybean epidemic asthma in Barcelona, Spain (33) , and the phenotype frequencies of DRI and DR4 are slightly increased in subjects sensitized to latex (34) .
Nonimmunologic or Irritant-Induced Occupational Asthma
The mechanisms of irritant-induced asthma are largely unknown, but a localized airway inflammatory response is likely involved. It is important to note that most patients who have sustained a toxic inhalational injury to their airways (chemical bronchitis) will recover without developing asthma. There are bronchial biospy data from patients who developed clinically evident asthma after exposure to high concentrations of irritants (e.g., RADS) that suggest that the histopathologic changes are similar to those of typical asthma, i.e., subepithelial fibrosis and infiltration of the mucosa/submucosa by eosinophils and T cells. However, the fibrosis tends to be greater and the T-cell infiltration/activation tends to be less (2, 35, 36) .
It has been hypothesized that irritantinduced epithelial damage is followed by direct activation of nonadrenergic, noncholinergic pathways via axon reflexes and onset of neurogenic inflammation (37) . Nonspecific macrophage activation and mast cell degranulation may also occur. Recruitment of other inflammatory cells likely enhances the inflammatory response. The damaged bronchial epithelium may contribute to the persistence of the inflammatory response by release of proinflammatory mediators but also may exhibit impaired function (e.g., reduced neutral endopeptidase activity, decreased generation of epithelial-derived relaxing factor). Irritant-induced airway inflammation may alter epithelial permeability such that subepithelial irritant receptors are more likely to be exposed to nonspecific stimuli such as cold air, exercise, cigarette smoke, and other inhaled irritants. Stimulation of these receptors may further increase the likelihood of persistence of airway inflammation and nonspecific airway hyperresponsiveness. Recovery from irritant-induced asthma appears to occur over time in many cases. However, the greater the initial injury, the more unlikely that complete recovery will occur. With severe injury, whether after a single high-concentration inhalation or multiple low-concentration exposures, there may be sufficient airway remodeling (i.e., deposition of type III collagen under the basement membrane) that complete recovery cannot occur.
Although much has been learned about the pathogenetic mechanisms underlying the various types of occupational asthma, little of this information has clinical applicability at this point because of important data gaps. This caveat is especially relevant to the issue of testing of workers for genetic susceptibility. Such testing cannot be recommended because there is not sufficient understanding of the interactions among genetic and environmental determinants of risk of occupational asthma.
Diagnosis
The diagnosis of occupational asthma is made by confirming the diagnosis of asthma and by establishing a relationship between asthma and work (38) (39) (40) (41) . Occupational asthma should be considered in every case of adultonset asthma or asthma that worsens in adult life (15, 40) .
Making a diagnosis of asthma requires the presence of both intermittent respiratory symptoms (e.g., cough, wheezing, chest tightness, and/or dyspnea) and physiologic evidence of reversible/variable airways obstruction or hyperresponsiveness. After the diagnosis of asthma is confirmed, the next step is to assess the patient's relationship with work, preferably by means of objective tests.
In general, the patient's history alone is not sufficient for the diagnosis of occupational asthma and is more likely to exclude than to confirm the diagnosis of occupational asthma (38, 42) . Objective confirmation of the diagnosis is necessary for both appropriate medical care and compensation purposes. It is important to recognize that no single test can be used to confirm the diagnosis in all cases.
Clinical Picture
Patients with occupational asthma may present with varying degrees of respiratory compromise, from mild symptoms to moderate or severe bronchospasm. In general, occupational asthma presents clinically in the same way as asthma of non-occupational origin. Mild cases of asthma may present with only episodic dry cough, chest tightness, and increased breathing effort. Signs and symptoms in more severely affected patients include wheezing, cough, chest tightness, shortness of breath, and dyspnea on exertion. Some patients with occupational asthma develop work-related bronchitis, characterized by recurrent episodes of cough and sputum production. Others may experience nocturnal awakening as an early manifestation of occupational asthma.
Rhinoconjunctivitis, which is manifested by ocular and nasal discharge and pruritus, and sneezing, may accompany respiratory symptoms. In a study comparing the occurrence of rhinoconjunctivis symptoms in workers exposed to HMW versus LMW substances, it was found that rhinoconjunctivitis occurred prior to the onset of occupational asthma in workers exposed to HMW substances; those exposed to LMW substances developed symptoms concurrently with their respiratory symptoms. It was postulated that HMW substances are more likely to invoke IgE-mediated immune responses that result in this temporal symptom pattern (43) .
In immunologic or sensitizer-induced occupational asthma, symptoms typically develop months or years after the onset of exposure. Substances that cause sensitizerinduced asthma may induce early, late, or dual airway responses (Figure 1 ). An In addition, the patient is asked to maintain a symptom diary, recording the time of day, the PEF reading, and any respiratory symptoms; these are evaluated by a physician on medical follow-up. At least 2 weeks of serial PEF recordings are needed to assess whether occupational asthma is likely. A 20% or greater diurnal variability in PEF has been used to diagnose workers with occupational asthma and a computerized system of analysis is under development, but at present, visual inspection of whether there is a work-related pattern of increased diurnal variability is probably the best approach to the analysis of serial peak flow recordings (38, 44) .
Currently there is debate about whether PEF readings are accurate, as they are dependent on patient effort and reliability. In a study of 17 subjects instructed in the use of a portable computerized peak flow meter who were unaware that their readings were being stored by the flow meter, it was found that only 55% of the records were completely accurate in terms of the recorded value and timing of the measurements (48 the presence of airflow limitation and its reversibility; in the absence of airflow limitation, the presence of nonspecific airway hyperresponsiveness; and the demonstration of work-relatedness of asthma by objective means (38) . The Canadian Thoracic Society has suggested a similar approach in making the diagnosis ofoccupational asthma, by demonstrating the presence of asthma with pulmonary function tests and then assessing the relationship between asthma and work (40) .
The National Institute for Occupational Safety and Health has recently updated its surveillance case definition and surveillance classification criteria for its state-based SENSOR programs for work-related asthma, which currently exist in California, Massachusetts, Michigan, and New Jersey (17) . Sentinel health events, which include cases of work-related asthma, indicate the need for preventive measures. Surveillance of work-related asthma may be accomplished by requiring health care professionals to report all diagnosed or suspected cases to state health departments. In analysis of these cases, the relative frequencies of classes of work-related asthma can be determined, as can gender frequencies, specific asthma-inducing agents, whether previously known or newly discovered, and the most common industries in which workers develop work-related asthma.
The SENSOR surveillance case definition for state health departments for work-related asthma includes: a) a health care professional's diagnosis consistent with asthma, and b) an association between symptoms of asthma and work. The SENSOR programs classify work-related asthma into three broad categories by using surveillance case classification criteria. These classes include occupational asthma, or work-induced asthma which is new in onset; work-aggravated asthma, which occurs in workers with preexisting asthma that has been treated within the past two years; and RADS, or irritantinduced asthma. The SENSOR case classification criteria are as follows: * Work-aggravated asthma is defined as preexisting asthma that was symptomatic and/or treated with asthma medication within the 2 years prior to entering the occupational setting associated with the patient's asthma symptoms. * RADS is defined as new asthma symptoms that develop within 24 hr after a one-time high-level inhalation exposure (at work) to an irritant gas, fume, smoke, or vapor and that persist for at least 3 months. * Occupational or work-induced asthma is defined as: a) workplace exposure to an agent previously associated with occupational asthma; or b) work-related changes in serially measured FEV, or PEF; or c) work-related changes in bronchial responsiveness as measured by serial nonspecific inhalation challenge testing; or d) positive response to specific inhalation challenge testing with an agent to which the patient has been exposed at work. Although the SENSOR surveillance case definition and classification criteria were designed for specific epidemiologic purposes, they provide a reasonable approach for the clinical evaluation of patients.
Management
The mainstay of treatment for occupational asthma is prompt diagnosis and removal of the worker from further exposure to the incitr ing agent if substitution with a less hazardous substance is not possible (15, (38) (39) (40) 44) . This is crucial in cases of sensitizer-induced occupational asthma, as very low exposures may trigger asthmatic reactions including status asthmaticus. Substances such as toluene diisocyanate have been reported to induce asthma in sensitized workers in the parts-per-billion range. Workers with irritant-induced or work-aggravated asthma may continue to work in their usual jobs if their exposure to the inciting agent is diminished through proper engineering controls or respiratory protective equipment if engineering controls are not feasible.
General Asthma Management
Patients diagnosed with occupational asthma should have medical management following published guidelines (53) . Since asthma is characterized by airway inflammation, inhaled corticosteroids have become a mainstay of treatment. Malo and colleagues (54) demonstrated that inhaled corticosteroids induce a small but significant overall improvement after withdrawal from exposure of patients with sensitizer-induced occupational asthma due to both HMW and LMW agents. In their double-blind crossover study, it was found that inhaled steroids were more beneficial if administered earlier rather than later after the diagnosis of occupational asthma.
Work Implications and Progosis
Occupational asthma can become a very disabling disease, resulting in long-term illness and a high rate of unemployment (55) . Subjects with occupational asthma suffer increased hospitalization rates for all causes, including cardiac and respiratory disease, compared to patients without asthma but lower hospitalization rates than among patients with nonoccupational asthma at a tertiary care center (56 (57) .
Multiple studies have confirmed that most workers with sensitizer-induced occupational asthma do not completely recover even after cessation of exposure to the causative agent (58, 59) . Persistent nonspecific airway hyperresponsiveness is frequent and is associated with chronic airway inflammation. Risk factors for persistent asthmatic symptoms and airway hyperresponsiveness are duration of exposure, duration of symptoms before removal from exposure, and severity of asthma at time of diagnosis (58, 60) . Early removal from exposure to a sensitizer increases the likelihood of recovery, and continued exposure in sensitized workers is associated with a worsening ofasthma (61) .
With cessation of exposure, spirometry and airway responsiveness tend to improve over time. In general, spirometric measures plateau in 1 year and bronchial responsiveness plateaus in 2 years (62. Lemiere and colleagues (63) found that a majority of subjects (60%) demonstrated decreased but persistent specific airway responsiveness after removal from exposure to the offending agent. Cessation of exposure to toluene diisocyanate in sensitized workers with occupational asthma is associated with a decrease in both the number of inflammatory cells in the airway mucosa and in the amount of subepithelial fibrosis observed with serial bronchial biopsies (64) .
Follow-up data on workers with irritantinduced asthma are sparse, but in one study a majority of pulp mill workers who developed symptoms of asthma after acute "gassing" episodes continued to have nonspecific airway hyperresponsiveness up to 2 years following their last exposures (65) .
Impairment/Disability Assessment
Because the majority of workers with occupational asthma continue to have some degree of respiratory impairment even several years after cessation of exposure, disability (i.e., decreased ability to work in one's usual and customary job, or if severe, in any job) is a common outcome. Rates of job loss or job change are high (66) (67) (68) (69) (70) . Disease severity plays a major role, but working conditions are a potent factor in determining who experiences disability and who does not (71) (72) (73) . As a consequence of this high rate of disability, occupational asthma often has a substantial socioeconomic impact, with one study (69) finding that approximately 50% of affected workers suffered a reduction in income 3 years after the diagnosis was made. Physicians are often asked to assist their patients diagnosed with occupational asthma to obtain workers' compensation for any disabilities caused by the disease.
Evaluation of level of impairment due to occupational asthma should be carried out as soon as the condition has been optimally treated and stabilized. Guidelines for impairment evaluation have been developed by the American Thoracic Society and endorsed by the American Medical Association (74, 75) . These guidelines use a scoring system that involves the following categories: postbronchodilator FEV1, reversibility of FEV1 or degree of nonspecific airway hyperresponsiveness, and minimum asthma medication need for optimal control of the disease. Ideally, follow-up evaluation should again be carried out when there is a change in dinical status.
Prevention
Prevention must be the primary tool for decreasing the incidence of and morbidity and disability from, occupational asthma, which can become a chronic disabling disease. Prevention must involve the expertise of occupational health personnel, industrial hygienists, engineers, chemists, and allergists (76) . It must also involve cooperation between employers, workers and their representatives, regulators, and medical personnel (77) .
The goal of primary prevention is to prevent occupational exposure. Primary prevention methods indude eliminating the sensitizing agent altogether by substitution with less hazardous substances, changing industrial processes, or reducing exposures. Secondary prevention detects asthma early so that its duration and severity can be minimized. The early detection of asthma in workers in highrisk industries such as the spray-painting industry where there is high exposure to diisocyanates is an example of secondary prevention. Tertiary prevention applies to individuals who have already been diagnosed with occupational asthma. It includes institution of appropriate health care and an effort to prevent permanent asthma by early removal of the subject from exposure (77) . Unfortunately, although removing ofworkers from the vicinity of the asthma-inducing agent may lead to symptomatic improvement, it may not prevent persistent asthma.
Engineering controls may be instituted to lower the risk of exposure to irritants and sensitizers when substitutes cannot be found. Such controls include local exhaust ventilation, process endosure, containment/isolation of hazardous exposures, and maintenance programs. Personal protective equipment such as respirators should only be considered measures of last resort. As in any industry with potential work-related hazards, proper worker education and training in work processes, safety equipment and procedures, and the use of material safety data sheets are of utmost importance.
Worplac Sureilnce
Another essential component in the prevention of occupational asthma is surveillance for occupational asthma in the workplace. Surveillance programs are a type of secondary prevention in that their principal goal is the early detection of asthma. In making an earlier diagnosis, morbidity and disability can be prevented through timely intervention. Any diagnosis of occupational asthma must be considered a sentinel event; other exposed workers are at risk and need to be identified promptly (18, 40, 46) .
A general approach to surveillance programs includes medical screening of co-workers as well as exposure monitoring (40, 46, 77) . The former falls under the jurisdiction of a medical department, whereas the latter is performed by industrial hygiene professionals. Ideally, both the medical and industrial hygiene components should be performed in tandem. Performing surveillance in high-risk industries such as those using diisocyanates is a prime example. In medical surveillance, short symptoms questionnaires can be administered annually and should include questions about whether improvement occurs in respiratory symptoms on weekends and holidays (40, 46, 77 Cross-shift spirometry can detect workers with acute work-related decrements in FEV1 but is insensitive for detecting late responses that may occur after work hours and requires on-site medical personnel for administration of the tests. Annual methacholine challenge testing has some theoretical appeal but is impractical to apply to a large number of exposed workers.
Future Research Needs
Although much insight into the pathogenesis of sensitizer-induced asthma has been gained over the past several decades, a better understanding of the mechanism(s) underlying asthma due to exposure to LMW-sensitizing agents such as the diisocyanates is needed. Of even greater need is a data-based framework for understanding the pathogenesis of irritantinduced asthma. Development of appropriate animal models would be a major advance. Although considerable progress has been made with regard to models of HMW sensitizerinduced asthma, models of LMW sensitizerinduced asthma (79) and irritant-induced asthma following a single high-concentration exposure are still in a relatively early stage of development (80 
Summary
Occupational asthma is currently the most common form of occupational lung disease in the developed world. The prevalence of this disease is likely to remain high for many years because about 250 industrial agents are known to cause the disease and new chemicals are continuously being introduced into the workplace. Diagnosis of occupational asthma is generally established on the basis of a history that suggests a temporal association between exposure and the onset of symptoms and objective evidence that these symptoms are related to airflow limitation. Current evidence suggests that early diagnosis, elimination of exposure to the responsible agent, and early use of inhaled steroids may play important roles in preventing the long-term persistence of asthma.
Persistent occupational asthma is often associated with substantial disability and consequent impacts on income and quality of life. Prevention of new cases is the best approach to reducing the burden of asthma attributable to occupational exposures. Despite considerable advances in our understanding of occupational asthma, more research is needed on pathogenesis, risk factors, exposure-response, long-term outcome, and effective preventive strategies.
